Reagents and instruments for immunology, cell biology and molecular biology.

Solutions for Scalable iPSC Expansion and Differentiation for Cell Therapy CMC

/upload/congress-1150-x-225-px-8-fd3ptb.jpg

Join our upcoming webinar titled "Solutions for Scalable Expansion and Differentiation of iPSCs for Cell Therapy CMC"

Overview

The induced pluripotent stem cell (iPSC) therapy market is rapidly evolving, driven by technological advances and the growing demand for regenerative medicine. As this field progresses, addressing the opportunities and challenges related to optimizing iPSC expansion and differentiation processes is crucial, ensuring both efficiency and consistency in cellular production. This webinar, titled "Solutions for Scalable Expansion and Differentiation of iPSCs for Cell Therapy CMC," will provide a comprehensive analysis of current market dynamics and examine innovative Chemistry, Manufacturing, and Controls (CMC) strategies essential for iPSC manufacturing and cell therapies. We will also delve into the stringent regulatory requirements defining the high standards of the industry. Join us to explore how these developments are shaping the future of iPSC therapy and contributing to the advancement of regenerative medicine.

Key Points:


Optimizing iPSC Storage and Differentiation	Innovative Chemistry, Manufacturing and Controls (CMC)	Regulatory Compliance in iPSC Therapy

Speaker

/upload/navy-blue-minimalist-business-con-e89abn.jpg

Idil Ariöz is a technical sales specialist at ACROBiosystems, based in Bonn, Germany. With a strong academic background in neuroscience, including a Ph.D. in Translational Neuroscience from Rheinische Friedrich-Wilhelms-Universität Bonn, she has expertise in neuronal regeneration, super-resolution imaging, and molecular biology.

At ACROBiosystems, Idil Ariöz has been involved in supporting and guiding clients, as well as developing promotional and co-marketing strategies, analyzing industry pain points. Prior to joining ACROBiosystems, Idil conducted academic scientific research in various fields of neuroscience, such as neuronal regeneration, spatial distribution of synaptic proteins at the nanometer scale, and molecular targets in epileptogenic neurodevelopmental diseases during her master's and Ph.D. studies.

At ACROBiosystems, GMP-grade reagents are supplied, which are essential for the clinical development of immune cell therapies, including CAR-T, NK cells, MSCs, and iPSCs. The state-of-the-art 20,000 square meter GMP production facility, combined with a robust quality management system, adheres to the stringent standards required for cell therapy drugs. A range of GMP auxiliary products has been specifically developed to support the manufacturing of these therapies. These products undergo strict quality management and release testing at the drug level to ensure their safety and efficacy, and are designed to accelerate clinical research and streamline global regulatory approvals.